Genomic alterations underlie a pan-cancer metabolic shift associated with tumour hypoxia
Altered metabolism is a hallmark of cancer. However, the role of genomic changes in metabolic genes driving the tumour metabolic shift remains to be elucidated. Here, we have investigated the genomic and transcriptomic changes underlying this shift across ten different cancer types.A systematic pan-...
Principais autores: | Haider, S, McIntyre, A, van Stiphout, R, Winchester, L, Wigfield, S, Harris, A, Buffa, F |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado em: |
BioMed Central
2016
|
Registros relacionados
-
The tumour hypoxia induced non-coding transcriptome.
por: Choudhry, H, et al.
Publicado em: (2016) -
Gene expression signatures as biomarkers of tumour hypoxia
por: Harris, B, et al.
Publicado em: (2015) -
Assessment of tumour hypoxia for prediction of response to therapy and cancer prognosis.
por: Jubb, A, et al.
Publicado em: (2010) -
The BET inhibitor JQ1 selectively impairs tumour response to hypoxia and downregulates CA9 and angiogenesis in triple negative breast cancer (TNBC)
por: Harris, A, et al.
Publicado em: (2016) -
Metabolic Shift and Hyperosmolarity Underlie Age-Related Macular Degeneration
por: Laurent Schwartz, et al.
Publicado em: (2024-09-01)